Navigation Links
Lilly Reports First-Quarter 2013 Results

INDIANAPOLIS, April 24, 2013 /PRNewswire/ --

  • Worldwide revenue was flat as growth in key products offset lower Zyprexa revenue following patent expirations.
  • Cymbalta revenue increased 19 percent while Cialis increased 11 percent.
  • Expense controls resulted in lower SG&A, offsetting growth in R&D expense.
  • First quarter 2013 results include income of $495 million related to the transfer to Amylin of exenatide commercial rights outside of the U.S.
  • Tax rate comparisons benefited from the reinstatement of the U.S. R&D tax credit.
  • First quarter earnings per share grew to $1.42 (reported), or $1.14 (non-GAAP).
  • 2013 earnings per share reconfirmed to be in the range of $4.10 to $4.25 (reported), or $3.82 to $3.97 (non-GAAP).
  • Eli Lilly and Company (NYSE: LLY) today announced financial results for the first quarter of 2013.$ in millions, except per share data

    First Quarter


    GrowthTotal Revenue – Reported


    0%Net Income – Reported


    53%EPS – Reported



    56%Net Income – non-GAAP


    22%EPS – non-GAAP



    Financial results for 2013 and 2012 are presented on both a reported and a non-GAAP basis. Some numbers in this press release may not add due to rounding. Reported results were prepared in accordance with generally accepted accounting principles (GAAP) and include all revenue and expenses recognized during the period. Non-GAAP results exclude the items described in the reconciliation tables later in the release. The non-GAAP results are presented in order to provide additional insights into the underlying trends in th

    SOURCE Eli Lilly and Company
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. DiversityInc Names Lilly a Top Company for Diversity
    2. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
    3. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
    4. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
    5. Lilly Oncology To Disclose New Pipeline Data At ASCO 2012
    6. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
    7. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
    8. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
    9. Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
    10. Lilly Diabetes Launches 8th Annual Diabetes Summer Camp Tour With Olympian Kris Freeman
    11. Lilly Declares Third-Quarter 2012 Dividend, Resumes Share Repurchase Program
    Post Your Comments:
    (Date:5/22/2015)... Texas , May 22, 2015 ... million in 2014 and is estimated to reach $90.7 million ... 2019. Browse through the TOC of North America ... segments, with the help of various tables and figures. ... receive 10% customization on this report.   ...
    (Date:5/22/2015)... Md. , May 22, 2015  RegeneRx Biopharmaceuticals, ... on tissue protection, repair and regeneration, today announced that ... is scheduled to present a corporate overview at two ... present at the SeeThruEquity 4 th Annual Microcap ... New York City at 11:00 am EDT. ...
    (Date:5/22/2015)... , May 22, 2015  The U.S. ... Zarxio (filgrastim-sndz) -- the first biosimilar product approved ... -- points toward growth in the contract manufacturing ... mainstream CMO industry is geared to the production ... produce major biopharmaceutical products. The healthcare market research ...
    Breaking Medicine Technology:North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
    ... 18, 2011 Bexion Pharmaceuticals was named the Biotech ... program sponsored by the Cincinnati Business Courier, the Cincinnati ... outstanding innovation and the companies and people who have ... for the regional Tri-State (Ohio/Kentucky/Indiana) economic engine. ...
    ... Md., April 18, 2011 Science, public ... Food and Drug Administration. I nformation in this document ... items are current as of April 18, 2011. ... & Notes does not contain any regulatory or enforcement actions ...
    Cached Medicine Technology:Bexion Pharmaceuticals Receives Outstanding Biotech Innovation Award 2FDA News & Notes - Week of April 18, 2011 2
    (Date:5/22/2015)... Gateway Building Concepts is experienced with all ... company specialize in include decks, additions, kitchen remodeling, interior ... much more. , The redesigned logo is a ... company. It includes two geometrical lines that represent the ... to be used with many things associated with the ...
    (Date:5/22/2015)... 22, 2015 A Phase 3 ... American Society of Clinical Oncology (ASCO)’s annual meeting ... rates for those patients who received bevacizumab in ... pemetrexed/cisplatin. Bevacizumab (Avastin® Genentech, Inc.) is an antibody ... is already routinely used to treat many other ...
    (Date:5/22/2015)... Ticket Down is a reputable source for authentic ... Finals Tickets . All seating for the 2015 NHL ... listing. , For the first time in some time, ... Eastern Conference. One of the original franchises in the National ... over the years, but the excitement level for this season ...
    (Date:5/22/2015)... In April 2006, Veatch Consulting opened ... years they have concentrated their focus to working with ... Because of this growth and their goals to better ... Denver, Colorado, Cleveland, Ohio, Houston, Texas and now Dallas, ... dental offices, dental start ups, orthodontic practices, pediatric dental ...
    (Date:5/22/2015)... 2015 Bryce Henson, local fitness icon ... Boot Camp, recently accepted his program’s 100th client. Henson ... launch of his location evidences the powerful impact his ... Fit Body Boot Camp is the nation’s most popular ... hundreds of locations across North America, Europe and Australia. ...
    Breaking Medicine News(10 mins):Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3Health News:Healthy Living Brought to Anaheim— New Fitness Boot Camp Acquires 100 Clients 2
    ... related to trend toward less sleep, researchers suspect ... many reasons why people should get adequate sleep, researchers now ... a component of type 2 diabetes. , The study included ... night of normal sleep (about eight hours) and after a ...
    ... ... "super chocolate", has been found effective in aiding weight loss. Users say it helps ... ... 2010 -- A special formulation of "super chocolate" has been fast increasing popularity among ...
    ... is safe, improves blood sugar control , THURSDAY, May ... have been encapsulated have been successfully transplanted into humans ... cells. , What,s more, scientists report, the transplanted pig ... to high blood sugar levels in the blood, improving ...
    ... Spring Harbor Laboratory in the USA have developed a powerful ... The breakthrough allows them to study in fine detail the ... help doctors identify dangerous tumor cells from small samples such ... in the breast. Dr James Hicks from Cold Spring ...
    ... study of metastatic breast cancer shows that the number ... directly correlates with the length of their survival. Reported ... the results have the potential to improve the delivery ... cells --cancer cells found in a patient,s bloodstream-- are ...
    ... to 10 million women take hormone therapies, which are ... hormones lost from inactive ovaries. Progestin is a hormone ... of estrogen therapy on the uterus. In studies sponsored ... found that estrogen and progestin in hormone therapies increase ...
    Cached Medicine News:Health News:One Sleepless Night Ups Insulin Resistance 2Health News:Super Fat-Melting Chocolate Recipe Revealed 2Health News:Super Fat-Melting Chocolate Recipe Revealed 3Health News:Pig Pancreas Cells Help Type 1 Diabetics 2Health News:Pig Pancreas Cells Help Type 1 Diabetics 3Health News:Genome breakthrough allows scientists to identify and profile tumor cells from very small samples 2Health News:Survival in metastatic breast cancer directly linked to circulating tumor cells 2Health News:Breast cancer metastasis increases after estrogen and progestin hormone therapies, MU study finds 2
    ... your practice with a practice management system. ... or on paper. Your patient statements can also ... has a combined traditional software and billing services ... any computer from anywhere - multiples offices or ...
    ... 3 mirrors angled at 76°, 66° and 60°. ... as well as central and peripheral fundus viewing ... accurately angled and spaced 120° apart to eliminate ... portion of the lens also provides direct observation ...
    ... Volk 3 mirror lenses featuring ultra-clear Volk ... at 76°, 66° and 60°. The ... as well central and peripheral fundus viewing ... accurately angled to eliminate gaps in the ...
    ... is a direct image lens ... air-filled eye. In addition to ... air-fluid exchange vitrectomy lens, the ... make it well suited for ...
    Medicine Products: